199 related articles for article (PubMed ID: 6117443)
1. Disposition and metabolism of timiperone in the rat, dog, and monkey.
Tachizawa H; Sudo K; Sasano H; Sano M
Drug Metab Dispos; 1981; 9(5):442-8. PubMed ID: 6117443
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
3. Disposition of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)- 1H-indole-3-methanol (59-801), a hypoglycaemic agent in rats, dogs and monkeys.
Tse FL; Orwig B; Jaffe JM
Xenobiotica; 1987 Jun; 17(6):741-9. PubMed ID: 3630208
[TBL] [Abstract][Full Text] [Related]
4. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
[TBL] [Abstract][Full Text] [Related]
6. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of the neuroleptic agent zetidoline in the rat and the dog.
Assandri A; Perazzi A; Fontanella L; Ferrari P; Ripamonti A; Tarzia G; Tuan G; Martinelli E
Drug Metab Dispos; 1984; 12(5):635-40. PubMed ID: 6149917
[TBL] [Abstract][Full Text] [Related]
8. Species differences in the metabolism and disposition of spironolactone.
Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of amlodipine in the rat and the dog: a species difference.
Beresford AP; Macrae PV; Stopher DA
Xenobiotica; 1988 Feb; 18(2):169-82. PubMed ID: 2967592
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys.
Hucker HB; Hutt JE; White SD; Arison BH; Zacchei AG
Drug Metab Dispos; 1983; 11(1):54-8. PubMed ID: 6132797
[TBL] [Abstract][Full Text] [Related]
12. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
Borondy PE; Michniewicz BM
Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of fenbufen in several laboratory animals.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
[TBL] [Abstract][Full Text] [Related]
14. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
Feng MR; Loo J; Wright J
Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
[TBL] [Abstract][Full Text] [Related]
15. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
Bechtel WD; Mierau J; Richter I; Stiasni M
Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
[TBL] [Abstract][Full Text] [Related]
16. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
[TBL] [Abstract][Full Text] [Related]
17. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of a new antihypertensive pyrrolyl pyridazinamine (MDL-899) in the rat and the dog.
Assandri A; Bellasio E; Bernareggi A; Cristina T; Perazzi A; Odasso G
Arzneimittelforschung; 1985; 35(2):508-13. PubMed ID: 3855234
[TBL] [Abstract][Full Text] [Related]
20. Disposition of timiperone, 4'-fluoro-4-[4-(2-thioxo-1-benzimidazolinyl)piperidino]butyrophenone, a neuroleptic, in the rat on repeated oral dosage.
Sudo K; Tachizawa H; Sano M
Xenobiotica; 1981 Oct; 11(10):685-91. PubMed ID: 6119853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
